pembrolizumab
merck
['keynote 651', 'keynote,651', 'pembro', 'rectal', 'colorectal']
live from #asco22: moffitt's dr. richard kim shares long-term follow up results for keynote 651 looking at pembrolizumab plus mfolfox7 or folfiri for metastatic colorectal cancer. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.